Follow
Howard Thames
Howard Thames
Professor of Biostatistics, Univ. TX MDAnderson Cancer Center
Verified email at mdanderson.org - Homepage
Title
Cited by
Cited by
Year
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix …
M Roach III, G Hanks, H Thames Jr, P Schellhammer, WU Shipley, ...
International Journal of Radiation Oncology* Biology* Physics 65 (4), 965-974, 2006
30462006
Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships
HD Thames Jr, HR Withers, LJ Peters, GH Fletcher
International Journal of Radiation Oncology* Biology* Physics 8 (2), 219-226, 1982
10561982
Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue
DJ Brenner, AA Martinez, GK Edmundson, C Mitchell, HD Thames, ...
International Journal of Radiation Oncology* Biology* Physics 52 (1), 6-13, 2002
8062002
Fractionation in radiotherapy
HD Thames, JH Hendry
(No Title), 1987
7001987
An ‘incomplete-repair’model for survival after fractionated and continuous irradiations
HD Thames
International Journal of Radiation Biology and Related Studies in Physics …, 1985
5691985
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis
WU Shipley, HD Thames, HM Sandler, GE Hanks, AL Zietman, CA Perez, ...
Jama 281 (17), 1598-1604, 1999
5481999
Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation
A Katz, EA Strom, TA Buchholz, HD Thames, CD Smith, A Jhingran, ...
Journal of clinical oncology 18 (15), 2817-2827, 2000
5222000
Accelerated fractionation vs hyperfractionation: rationales for several treatments per day
HD Thames Jr, LT Peters, HR Withers, GH Fletcher
International Journal of Radiation Oncology* Biology* Physics 9 (2), 127-138, 1983
4981983
Time-dose factors in radiotherapy: a review of the human data
HD Thames, SM Bentzen, I Turesson, M Overgaard, W Van den Bogaert
Radiotherapy and Oncology 19 (3), 219-235, 1990
4941990
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience
AM Chen, F Meric-Bernstam, KK Hunt, HD Thames, MJ Oswald, ...
Journal of Clinical Oncology 22 (12), 2303-2312, 2004
4912004
A new isoeffect curve for change in dose per fraction
HR Withers, HD Thames Jr, LJ Peters
Radiotherapy and Oncology 1 (2), 187-191, 1983
4241983
Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up
I Turesson, HD Thames
Radiotherapy and Oncology 15 (2), 169-188, 1989
3841989
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non–small-cell lung cancer receiving concomitant chemoradiotherapy
ZX Liao, RR Komaki, HD Thames Jr, HH Liu, SL Tucker, R Mohan, ...
International Journal of Radiation Oncology* Biology* Physics 76 (3), 775-781, 2010
3692010
Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era
DA Kuban, HD Thames, LB Levy, EM Horwitz, PA Kupelian, AA Martinez, ...
International Journal of Radiation Oncology* Biology* Physics 57 (4), 915-928, 2003
3342003
Accelerated fractionation in the radiation treatment of head and neck cancer—a critical comparison of different strategies
LJ Peters, KK Ang, HD Thames
Acta oncologica 27 (2), 185-194, 1988
3251988
Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis
R Tao, S Krishnan, PR Bhosale, MM Javle, TA Aloia, RT Shroff, AO Kaseb, ...
Journal of Clinical Oncology 34 (3), 219-226, 2016
2992016
Clinical radiobiology of malignant melanoma
SM Bentzen, J Overgaard, HD Thames, M Overgaard, PV Hansen, ...
Radiotherapy and Oncology 16 (3), 169-182, 1989
2851989
Tumor volume: a basic and specific response predictor in radiotherapy
HH Dubben, HD Thames, HP Beck-Bornholdt
Radiotherapy and oncology 47 (2), 167-174, 1998
2771998
Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study
SM Bentzen, HD Thames, M Overgaard
Radiotherapy and Oncology 15 (3), 267-274, 1989
2601989
Response to preoperative chemoradiation increases the use of sphincter‐preserving surgery in patients with locally advanced low rectal carcinoma
CH Crane, JM Skibber, BW Feig, JN Vauthey, HD Thames, SA Curley, ...
Cancer 97 (2), 517-524, 2003
2532003
The system can't perform the operation now. Try again later.
Articles 1–20